Skip to main content
Top
Published in: Digestive Diseases and Sciences 7/2010

01-07-2010 | Original Article

Trends in Gastroesophageal Reflux Disease as Measured by the National Ambulatory Medical Care Survey

Authors: Frank K. Friedenberg, Alexandra Hanlon, Vishwas Vanar, Dawit Nehemia, Jyothi Mekapati, Deborah B. Nelson, Joel E. Richter

Published in: Digestive Diseases and Sciences | Issue 7/2010

Login to get access

Abstract

Background

The prevalence of reflux disease is increasing. Health-care utilization including physician visits for this disorder is lacking. Our purpose was to analyze the trend in physician visits for GERD from the period 1995–2006 using the National Ambulatory Medical Care Survey. We also sought to determine health-care utilization for GERD indirectly by assessing prescription trends for proton-pump inhibitors and H2 receptor blockers during the period.

Methods

The National Ambulatory Medical Care Survey is a survey of approximately 3,000 office-based physicians that uses a three-stage probability sampling procedure to allow extrapolation to the US population. All visits between 1995 and 2006 for symptoms and/or diagnoses compatible with GERD were combined into a single categorical variable. Weighted data was utilized for descriptive and inferential statistical analysis.

Results

After weighting, there were N = 321,513 adult ambulatory care encounters for all diagnoses. Visits for reflux increased throughout the examined period. Using logistic regression, visits for reflux were associated with female gender, age over 40, and calcium channel blocker use. Proton-pump inhibitor use increased substantially during the study period while H2 blocker use declined. Family practitioners and internists saw the majority of reflux patients.

Conclusions

The frequency of ambulatory visits in the United States for gastroesophageal reflux disease increased significantly between 1995 and 2006. The use of PPI therapy is increasing even more substantially. Older age, female gender, and use of calcium channel blockers were associated with a higher frequency of GERD visits. Health-care utilization for this disorder is increasing perhaps due to our ever-increasing epidemic of obesity.
Literature
1.
go back to reference Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990;335(8683):205–208.CrossRefPubMed Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990;335(8683):205–208.CrossRefPubMed
5.
go back to reference Thompson WG, Heaton KW. Heartburn and globus in apparently healthy people. Can Med Assoc J. 1982;126(1):46–48.PubMed Thompson WG, Heaton KW. Heartburn and globus in apparently healthy people. Can Med Assoc J. 1982;126(1):46–48.PubMed
10.
go back to reference Agreus L, Svardsudd K, Talley NJ, et al. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol. 2001;96(10):2905–2914.PubMed Agreus L, Svardsudd K, Talley NJ, et al. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol. 2001;96(10):2905–2914.PubMed
15.
go back to reference Castell DO. A practical approach to heartburn. Hosp Pract (Minneap). 1999;34(12):89–94. 97–98.CrossRef Castell DO. A practical approach to heartburn. Hosp Pract (Minneap). 1999;34(12):89–94. 97–98.CrossRef
17.
go back to reference Balkrishnan R, Sansbury JC, Shenolikar RA, et al. Prescribing patterns for topical retinoids within NAMCS data. J Drugs Dermatol. 2005;4(2):172–179.PubMed Balkrishnan R, Sansbury JC, Shenolikar RA, et al. Prescribing patterns for topical retinoids within NAMCS data. J Drugs Dermatol. 2005;4(2):172–179.PubMed
18.
go back to reference Gupta AK, Cooper EA, Feldman SR, et al. A survey of office visits for actinic keratosis as reported by NAMCS, 1990–1999. National Ambulatory Medical Care Survey. Cutis. 2002;70(Suppl(2)):8–13.PubMed Gupta AK, Cooper EA, Feldman SR, et al. A survey of office visits for actinic keratosis as reported by NAMCS, 1990–1999. National Ambulatory Medical Care Survey. Cutis. 2002;70(Suppl(2)):8–13.PubMed
23.
go back to reference Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med. 1999;130(11):883–890.PubMed Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med. 1999;130(11):883–890.PubMed
26.
go back to reference Jenkinson LR, Norris TL, Watson A. Gastro-oesophageal reflux associated with nifedipine. Aliment Pharmacol Ther. 1988;2(4):337–339.PubMedCrossRef Jenkinson LR, Norris TL, Watson A. Gastro-oesophageal reflux associated with nifedipine. Aliment Pharmacol Ther. 1988;2(4):337–339.PubMedCrossRef
27.
go back to reference Lagergren J, Bergstrom R, Adami HO, Nyren O. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med. 2000;133:165–175.PubMed Lagergren J, Bergstrom R, Adami HO, Nyren O. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med. 2000;133:165–175.PubMed
28.
go back to reference Locke GR III, Talley NJ, Fett SL, et al. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med. 1999;106:642–649.CrossRefPubMed Locke GR III, Talley NJ, Fett SL, et al. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med. 1999;106:642–649.CrossRefPubMed
29.
go back to reference Ruigomez A, Wallander MA, Johansson S, et al. Natural history of gastroesophageal reflux disease diagnosed in UK general practice. Aliment Pharmacol Ther. 2004;20:751–760.CrossRefPubMed Ruigomez A, Wallander MA, Johansson S, et al. Natural history of gastroesophageal reflux disease diagnosed in UK general practice. Aliment Pharmacol Ther. 2004;20:751–760.CrossRefPubMed
Metadata
Title
Trends in Gastroesophageal Reflux Disease as Measured by the National Ambulatory Medical Care Survey
Authors
Frank K. Friedenberg
Alexandra Hanlon
Vishwas Vanar
Dawit Nehemia
Jyothi Mekapati
Deborah B. Nelson
Joel E. Richter
Publication date
01-07-2010
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 7/2010
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-009-1004-0

Other articles of this Issue 7/2010

Digestive Diseases and Sciences 7/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine